Sort
48,018 grants matching “immunotherapy”
Tumor selective inhibition of the WNT pathway
$568,218Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Adoptive immunotherapy after umbilical cord blood transplant
$568,179Laurence J.n. Cooper · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Finding the optimal balance of immunotherapy efficacy and toxicity.
$568,167David Eric Gerber · Ut Southwestern Medical Center · U01 · FY2023 · AI
Testing the role of BATF as a pioneer transcription factor in effector T cells
$568,163William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2015 · AI
Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis
$568,115Natalia B Ivanova · University Of Georgia · R01 · FY2025 · HL
Specific Adoptive Immunotherapy of Leukemia
$568,090Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2010 · CA
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$568,084Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Coordinating Center for Canine Immunotherapy Trials and Correlative Studies
$567,985Nicola J Mason · University Of Pennsylvania · U24 · FY2021 · CA
METASTATIC COLORECTAL CANCER IMMUNOTHERAPY WITH GUCY2C-EXPRESSING LISTERIA MONOCYTOGENES
$567,969Thomas Jefferson University · · FY2017 · Department of the Army
Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses
$567,817Benjamin George Keselowsky · University Of Florida · R01 · FY2017 · DE
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
$567,816Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Development of new passive immunization strategies for anthrax
$567,768Arturo Casadevall · Columbia University Health Sciences · U54 · FY2011 · AI
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$567,760Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
$567,734Brian T Campfield · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$567,683Alejandro V Villagra · Georgetown University · R01 · FY2024 · CA
Engineered extracellular vesicles derived from mesenchymal stem cells for the treatment of type 1 diabetes
$567,641Ryang Hwa Lee · Texas A&M University Health Science Ctr · R01 · FY2024 · DK
VIRAL IMMUNOTHERAPY TO ERADICATE SUBCLINICAL BRAIN METASTASES
$567,503University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2011 · Department of Defense
Cytek Aurora CS
$567,400Eric P Skaar · Vanderbilt University Medical Center · S10 · FY2023 · OD
Career Development in Pediatric and Medical Oncology
$567,345Soheil Meshinchi · Fred Hutchinson Cancer Center · K12 · FY2023 · CA
Coordinating Center for Canine Immunotherapy Trials and Correlative Studies
$567,292Nicola J Mason · University Of Pennsylvania · U24 · FY2020 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$567,204Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2024 · CA
MECHANISMS OF MURINE TUMOR ERADICATION BY IMMUNOTHERAPY
$567,199Philip D Greenberg · University Of Washington · R37 · FY2006 · CA
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$567,157Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Dendritic Cell mediated induction of Anti-HCV immunity
$567,063Nina Bhardwaj · New York University School Of Medicine · R01 · FY2007 · AI
Project 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.
$567,040Edward A Stadtmauer · University Of Pennsylvania · P01 · FY2021 · CA